Scarica l'app Stockscreener
1.03
1.28%
0.00
Precedente Chiudi:
$1.03
Aprire:
$1.05
Volume 24 ore:
1,364
Relative Volume:
0.01
Capitalizzazione di mercato:
$34.85M
Reddito:
-
Utile/perdita netta:
$-13.27M
Rapporto P/E:
-6.2805
EPS:
-0.164
Flusso di cassa netto:
$-7.70M
1 W Prestazione:
+1.28%
1M Prestazione:
+5.37%
6M Prestazione:
-29.27%
1 anno Prestazione:
-47.58%
Intervallo 1D:
$1.035
$1.0507
Intervallo di 1 settimana:
$0.973
$1.1351
Portata 52W:
$0.8075
$2.95
Okyo Pharma Limited Stock (OKYO) Company Profile
Nome
Okyo Pharma Limited
Settore
Industria
Telefono
-
Indirizzo
-
Okyo Pharma Limited Borsa (OKYO) Ultime notizie
OKYO Pharma executive chairman increases stake - Investing.com
OKYO Pharma executive chairman increases stake By Investing.com - Investing.com UK
OKYO Pharma executive increases stake in company - Investing.com
OKYO Pharma executive increases stake in company By Investing.com - Investing.com Canada
OKYO Pharma Chairman Boosts Stake, Advances Trials - TipRanks
Okyo Pharma announces acquisition of shares by chairman - TipRanks
OKYO Pharma Announces Chairman Acquires Shares - GlobeNewswire
OKYO Pharma chair increases shareholdings - Proactive Investors USA
OKYO Pharma Announces Chairman Acquires Shares - Yahoo Finance UK
OKYO Pharma Announces Chairman Acquires Shares - Informazione.it
OKYO Pharma executive increases stake - Investing.com
OKYO Pharma Ltd expected to post a loss of 11 cents a shareEarnings Preview - XM
OKYO Pharma executive increases stake By Investing.com - Investing.com Canada
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease - Yahoo Finance UK
OKYO Pharma executive increases stake - Investing.com India
OKYO Pharma executive increases stake By Investing.com - Investing.com UK
OKYO Pharma executive increases stake in company By Investing.com - Investing.com UK
OKYO Pharma (NASDAQ:OKYO) & Moderna (NASDAQ:MRNA) Financial Analysis - Defense World
OKYO Pharma stock poised for potential gains ahead of Phase 2b dataH.C. Wainwright - Investing.com
OKYO Pharma (NASDAQ:OKYO) Receives Buy Rating from HC Wainwright - Defense World
OKYO Pharma (LON:OKYO) Trading Down 24.3% - Defense World
OKYO Pharma secures US patent for dry eye disease therapy - Investing.com
OKYO Pharma secures key US patent for dry eye disease treatment - Investing.com
OKYO Pharma Secures U.S. Patent for DED Therapy - TipRanks
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease - GlobeNewswire
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease - StockTitan
OKYO Pharma secures key US patent for dry eye disease therapy - Proactive Investors UK
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease - Yahoo Finance
OKYO Pharma Exec Chairman Increases Stake - Investing.com India
The Significance of Moving Averages in OKYO Pharma Limited Inc. (OKYO) Price Performance - The InvestChronicle
OKYO Pharma Exec Chairman Increases Stake By Investing.com - Investing.com Canada
OKYO Pharma Exec Chairman Increases Stake By Investing.com - Investing.com Australia
OKYO Pharma CEO Interview to Air on Bloomberg TV - Yahoo Finance UK
OKYO Pharma Advances in Ocular Disease Therapies - TipRanks
OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
OKYO Pharma CEO Interview to Air on Bloomberg TV - GlobeNewswire
OKYO Pharma and SolarMax Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - StockTitan
OKYO Pharma Exec Chairman Increases Stake - Investing.com
OKYO Pharma Exec Chairman Increases Stake By Investing.com - Investing.com UK
OKYO Pharma Chairman Buys More Shares - TipRanks
OKYO Pharma CEO Interview to Air on Bloomberg TV - Informazione.it
OKYO Pharma executive chairman increases stake By Investing.com - Investing.com Australia
OKYO Pharma executive increases stake in company By Investing.com - Investing.com Australia
OKYO Pharma chairman acquires more shares in the company - Proactive Investors USA
OKYO Pharma Chairman Boosts Shareholding - TipRanks
OKYO Pharma Announces Chairman Acquires Shares - StockTitan
OKYO Pharma to present at ophthalmology conference By Investing.com - Investing.com Australia
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Marketscreener.com
OKYO Pharma Showcases OK-101 at Ophthalmology Conference - TipRanks
OKYO Pharma to present at ophthalmology conference - Investing.com
OKYO Pharma to participate in virtual ophthalmology conference - Proactive Investors UK
Okyo Pharma Limited Azioni (OKYO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
1.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):